Examples of 'canagliflozin' in a sentence
Meaning of "canagliflozin"
Canagliflozin is a noun that refers to a medication used to treat type 2 diabetes by helping the kidneys remove glucose from the bloodstream through the urine
Show more definitions
- A drug C₂₄H₂₅FO₅S·½H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet.
How to use "canagliflozin" in a sentence
Basic
Advanced
canagliflozin
Canagliflozin should not be used during pregnancy.
Protein binding is independent of canagliflozin plasma concentrations.
Canagliflozin is not expected to be dialysable by peritoneal dialysis.
Cholestyramine may potentially reduce canagliflozin exposure.
Canagliflozin as initial combination therapy with metformin.
The active substances are canagliflozin and metformin hydrochloride.
Canagliflozin should be discontinued when eGFR is persistently below.
These decreases in exposure to canagliflozin may decrease efficacy.
Canagliflozin has not been studied in severe renal impairment.
Based on postmarketing experience with canagliflozin.
Effects of canagliflozin on other medicinal products.
Studies have shown no glucose malabsorption with canagliflozin.
The dose of canagliflozin can then be increased if needed.
Crystallization procedure for obtaining canagliflozin hemihydrate crystals.
These increases in canagliflozin exposure are not expected to be clinically relevant.
See also
The active substance is canagliflozin.
In patients tolerating canagliflozin whose eGFR falls persistently below.
Canagliflozin was negligibly removed by haemodialysis.
Enterohepatic circulation of canagliflozin was negligible.
The effect of canagliflozin on fertility in humans has not been studied.
There are no data from the use of canagliflozin in pregnant women.
Canagliflozin should not be initiated.
Subjects responded to standard treatments while continuing canagliflozin treatment.
Diabetes medicine canagliflozin may contribute to risk of toe amputation.
Its chemical name is canagliflozin.
Disclosed is canagliflozin in combination with probenecid for use as a medicament.
Pharmacodynamic effects of canagliflozin.
Canagliflozin is not recommended for use in patients receiving loop diuretics.
Invokana is a diabetes medicine that contains the active substance canagliflozin.
Vokanamet can also be used to replace canagliflozin and metformin given separately.
Side effects when taking metformin alone that were not described for canagliflozin.
Studies characterising the pharmacokinetics of canagliflozin in paediatric patients have not been conducted.
Most reports of vulvovaginal candidiasis occurred during the first four months of treatment with canagliflozin.
In patients already being treated with the combination of canagliflozin and metformin as separate tablets.
Patients treated with canagliflozin regardless of baseline eGFR experienced an initial fall in mean eGFR.
For patients switching from separate tablets of canagliflozin and metformin.
Canagliflozin and Cardiovascular.
Empagliflozin contains tetrahydrofuran ring but not canagliflozin nor dapagliflozin.
Canagliflozin should not be used during breast-feeding.
The reason for the increase in amputation risk with canagliflozin is unknown.
Canagliflozin + metformin and sulphonylurea.
Vokanamet is a diabetes medicine that contains the active substances canagliflozin and metformin.
There are no data from the use of canagliflozin alone or Vokanamet in pregnant women.
The PRAC has initiated a review of the safety of the diabetes medicine canagliflozin.
Canagliflozin works by blocking the body 's reabsorption of sugar or glucose.
The clinical trial reported cases of amputations in both the canagliflozin and placebo groups.
It is unknown whether canagliflozin and / or its metabolites are excreted in human milk.
Field of Invention The present invention relates to process of preparation of canagliflozin.
When pregnancy is detected, treatment with canagliflozin should be discontinued.
Invokana and Invokamet are two pharmaceuticals that contain a compound known as Canagliflozin.
